Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force

For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and weight gain with some SUs have led to discussion on...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Indian J Endocrinol Metab
Egile Nagusiak: Kalra, Sanjay, Bahendeka, Silver, Sahay, Rakesh, Ghosh, Sujoy, Md, Fariduddin, Orabi, Abbas, Ramaiya, Kaushik, Al Shammari, Sameer, Shrestha, Dina, Shaikh, Khalid, Abhayaratna, Sachitha, Shrestha, Pradeep K., Mahalingam, Aravinthan, Askheta, Mazen, A. Rahim, Aly Ahmed, Eliana, Fatimah, Shrestha, Hari K., Chaudhary, Sandeep, Ngugi, Nancy, Mbanya, Jean Claude, Aye, Than Than, Latt, Tint Swe, Akanov, Zhanay A., Syed, Abbas Raza, Tandon, Nikhil, Unnikrishnan, A. G., Madhu, S. V., Jawa, Ali, Chowdhury, Subhankar, Bajaj, Sarita, Das, Ashok Kumar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medknow Publications & Media Pvt Ltd 2018
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
https://ncbi.nlm.nih.gov/pubmed/29535952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijem.IJEM_556_17
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak